Vadimezan
- CAS No.
- 117570-53-3
- Chemical Name:
- Vadimezan
- Synonyms
- DMXAA;DMAXX;AS1404;ASA-404;CS-1975;AS 1404;AS-1404;vadimezan;NSC-649488;NSC-640488
- CBNumber:
- CB5503379
- Molecular Formula:
- C17H14O4
- Molecular Weight:
- 282.29
- MDL Number:
- MFCD00870555
- MOL File:
- 117570-53-3.mol
- MSDS File:
- SDS
| Melting point | 259-261 °C |
|---|---|
| Boiling point | 520.9±50.0 °C(Predicted) |
| Density | 1.321±0.06 g/cm3(Predicted) |
| vapor pressure | 0Pa at 20℃ |
| storage temp. | 2-8°C |
| solubility | DMSO: 17 mg/mL, soluble |
| form | solid |
| pka | 4.21±0.10(Predicted) |
| color | light brown |
| Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or DMF may be stored at -20°C for up to 3 months. |
| FDA UNII | 0829J8133H |
| NCI Drug Dictionary | vadimezan |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS07,GHS09 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H400 | |||||||||
| Precautionary statements | P273-P301+P312+P330 | |||||||||
| Hazard Codes | Xn,N | |||||||||
| Risk Statements | 22-50/53 | |||||||||
| Safety Statements | 60-61 | |||||||||
| RIDADR | UN 3077 9/PG 3 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | ZD5536200 | |||||||||
| HS Code | 2932.99.7000 | |||||||||
| NFPA 704 |
|
Vadimezan price More Price(50)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | D5817 | DMXAA ≥98% (HPLC), solid | 117570-53-3 | 5mg | $256 | 2024-03-01 | Buy |
| Sigma-Aldrich | D5817 | DMXAA ≥98% (HPLC), solid | 117570-53-3 | 25mg | $875 | 2024-03-01 | Buy |
| TCI Chemical | D5235 | Vadimezan | 117570-53-3 | 50MG | $158 | 2024-03-01 | Buy |
| TCI Chemical | D5235 | Vadimezan | 117570-53-3 | 250MG | $504 | 2024-03-01 | Buy |
| Cayman Chemical | 14617 | DMXAA ≥98% | 117570-53-3 | 1mg | $32 | 2024-03-01 | Buy |
Vadimezan Chemical Properties,Uses,Production
Description
DMXAA (117570-53-3) is a STING (Stimulator of Interferon Genes) agonist selective for mouse STING.1,2 Intratumoral administration of DMXAA resulted in tumor regression and complete rejection in mouse xenografts.3 Tumor regression induced by DMXAA results from a cascade of cellular events which include disruption of tumor vasculature followed by the release of chemokines which trigger the recruitment of immune cells.4 DMXAA induced expression of IFN-β resulting in a striking expansion of leukemia-specific T cells extending survival in two acute myeloid leukemia models.5
Uses
Vadimezan is a drug that displayed vascular-disrupting activity and induced haemorrhagic necrosis and tumour regression in pre-clinical animal models. It is a substrate for the immune adaptor protein STING in mice.
Definition
ChEBI: A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 5,6-dimethyl-9-oxoxanthen-4-yl group.
General Description
5,6-dimethylxanthenone-4-acetic acid (DMXAA) is a flavone acetic acid derivative. It acts as a vascular disrupting agent (VDA), which damages tumor vasculature and stimulates an anti-tumor immune response. It stimulates hemorrhagic necrosis.
Biochem/physiol Actions
DMXAA is an apoptosis inducer; anti-vascular.
storage
Store at +4°C
References
1) Prantner et al. (2012), 5,6-Dimethylzanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential; J. Biol. Chem., 287 39776 2) Conlon et al. (2013), Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid; J. Immunol., 190 5216 3) Corrales et al. (2015), Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and immunity; Cell Rep., 11 1018 4) Weiss et al. (2017), The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression; Oncoimmunology, 6 e1346765 5) Curran et al. (2016), STING Pathway Activation Stimulates Potent Immunity Against Acute Myeloid Leukemia; Cell Rep., 15 2357
Vadimezan Preparation Products And Raw materials
Raw materials
1of4
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Capot Chemical Co.,Ltd. | +86-（0）57185586718 +86-13336195806 | sales@capot.com | China | 29791 | 60 |
| Shanghai Daken Advanced Materials Co.,Ltd | +86-371-66670886 | info@dakenam.com | China | 18751 | 58 |
| Hangzhou FandaChem Co.,Ltd. | +8615858145714 | FandaChem@Gmail.com | China | 9087 | 55 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32957 | 60 |
| Shanghai Zheyan Biotech Co., Ltd. | 18017610038 | zheyansh@163.com | CHINA | 3619 | 58 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29880 | 58 |
| Biochempartner | 0086-13720134139 | candy@biochempartner.com | CHINA | 965 | 58 |
| Hubei Jusheng Technology Co.,Ltd. | 18871490254 | linda@hubeijusheng.com | CHINA | 28172 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
| Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 | sales@chemdad.com | China | 39894 | 58 |
View Lastest Price from Vadimezan manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2024-11-17 | Vadimezan
117570-53-3
|
US $48.00-239.00 / mg | ≥98% | 10g | TargetMol Chemicals Inc. | ||
 |
2019-07-06 | 5,6-Dimethylxantheonone-4-acetic acid
117570-53-3
|
US $2.00 / kg | 1kg | 99% | 100kg | Career Henan Chemical Co |
-
- Vadimezan
117570-53-3
- US $48.00-239.00 / mg
- ≥98%
- TargetMol Chemicals Inc.
-
- 5,6-Dimethylxantheonone-4-acetic acid
117570-53-3
- US $2.00 / kg
- 99%
- Career Henan Chemical Co